Kaye Mark 4
4 · CONMED Corp · Filed Feb 26, 2025
Insider Transaction Report
Form 4
CONMED CorpCNMD
Kaye Mark
Director
Transactions
- Award
Options To Purchase Common Stock
2025-02-24+1,846→ 1,846 totalExercise: $61.97From: 2026-02-24Exp: 2035-02-24→ Common Stock (1,846 underlying) - Award
RSUs (Restricted Stock Units)
2025-02-24+152→ 152 totalExercise: $0.00From: 2026-02-24Exp: 2035-02-24→ Common Stock (152 underlying)
Footnotes (2)
- [F1]The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.